Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
Open Access
- 21 September 2009
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 10 (1) , 113
Abstract
Occurrence of atrial fibrillation (AF) amongst bisphosphonate users has been increasingly reported but results are conflicting. We performed a Bayesian meta-analysis to address the possible association between the occurrence of AF and bisphosphonate use and estimated the posterior probability of development of AF with bisphosphonate use.Keywords
This publication has 37 references indexed in Scilit:
- Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control studyBMJ, 2008
- Alendronate for the treatment of osteoporosis in menExpert Opinion on Pharmacotherapy, 2008
- Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenCochrane Database of Systematic Reviews, 2008
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureNew England Journal of Medicine, 2007
- Alendronate and Atrial FibrillationNew England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyAnnals of the Rheumatic Diseases, 2006
- Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosisBone, 2004
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996